PDCD1 and neoplasm: In this study, we used imaging mass cytometry (IMC) to explore the composition and spatial arrangements of different immune and stromal cells in the vicinity of cancer cells in baseline tumor samples from 26 advanced melanoma patients treated with anti-PD-1 monoclonal antibody at Peking University Cancer Hospital and Institute (PUCH), Beijing, China.